跳至主要内容
临床试验/EUCTR2005-000049-12-GB
EUCTR2005-000049-12-GB进行中(未招募)1 期

The effects of testosterone therapy in men with pulmonary hypertension

Sheffield teaching Hospitals NHS Foundation Trust0 个研究点目标入组 0 人开始时间: 2005年2月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Male aged over 18 on regular medication unlikely to change
  • Clinical pulmonary hypertension, diagnosed 3 months and clinically stable
  • Pulmonary hypertension diagnosed on echocardiography or by right heart catheter: peak systolic pulmonary artery pressure>50mmHg, mean 30mmHg.
  • NYHA class II or III
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Unable to perform shuttle walk test or comply with medication
  • Malignancy e.g. breast and prostate.
  • Left heart failure – Ejection fraction <40% on echocardiography
  • Nephrotic syndrome
  • History of primary liver tumours
  • Hypercalcaemia and hypercalciuria
  • Hormone manipulating therapy
  • PSA above the normal range
  • NYHA class IV
  • Current participation in other research projects

研究者

相似试验